Press Releases

24 March 2022

7th National Batho Pele Excellence awarded to Professor Helen Rees

7th National Batho Pele Excellence awarded to Professor Helen Rees

18 March 2022

Unitaid to introduce new long-lasting injection to prevent HIV in Brazil and South Africa

Unitaid to introduce new long-lasting injection to prevent HIV in Brazil and South Africa, as high-income countries begin deployment

01 March 2022

French National Order of Merit Awarded to Professor Helen Rees

This accolade recognises her outstanding medical career and commitment to improving global health with a focus on public health in Africa

17 February 2022

The Global Polio Eradication Initiative (GPEI) Statement on WPV1 in Malawi

The GPEI is supporting health authorities in Malawi to conduct a thorough assessment of the situation and begin urgent immunization activities in the subregion to mitigate any risk of spread

15 February 2022

What do young women in Africa want for HIV prevention? They want choice.

Results of REACH study suggests monthly dapivirine vaginal ring would be a viable option for those who can’t or choose not to use daily oral PrEP, researchers report at CROI

01 February 2022

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

22 December 2021

Wits RHI applauds the US FDA’s approval of the first ever long-acting HIV prevention injection

Drug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epidemic in Africa

17 August 2021

MOSAIC has launched

A new US$85 million program to help women in multiple countries in sub-Saharan Africa protect themselves from HIV has been launched, MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention), is implemented by a consortium of partners led by FHI 360 with a range of local partners. Wits RHI is part of the core strategic leadership group for all consortium activities.

15 July 2021

REACH Study finds adolescent girls and young women in Africa will use HIV prevention products

Interim results of the REACH study of daily oral PrEP and monthly dapivirine vaginal ring presented at IAS 2021 – the 11th IAS Conference on HIV Science

10 November 2020

HIV drug study shows long-acting injection is more effective than current daily HIV pill

Early unblinding of the pre-exposure prophylaxis regimen of long-acting cabotegravir (CAB LA) is a milestone for prevention of HIV among women in sub Saharan Africa